A new trading day began on Friday, with CVS Health Corp (NYSE: CVS) stock price down -1.58% from the previous day of trading, before settling in for the closing price of $69.74. CVS’s price has ranged from $64.41 to $83.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 13.36%. Meanwhile, its annual earnings per share averaged -5.17%. With a float of $1.26 billion, this company’s outstanding shares have now reached $1.29 billion.
The extent of productivity of a business whose workforce counts for 300000 workers is very important to gauge.
CVS Health Corp (CVS) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Healthcare Plans Industry. The insider ownership of CVS Health Corp is 0.19%, while institutional ownership is 82.32%. The most recent insider transaction that took place on Feb 16 ’24, was worth 2,267,947. In this transaction EVP and Pres-Pharm, Consumer W of this company sold 29,473 shares at a rate of $76.95, taking the stock ownership to the 39,765 shares. Before that another transaction happened on Nov 03 ’23, when Company’s Director bought 2,000 for $70.47, making the entire transaction worth $140,930. This insider now owns 20,630 shares in total.
CVS Health Corp (CVS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 68.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.17% per share during the next fiscal year.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Here are CVS Health Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.24. Likewise, its price to free cash flow for the trailing twelve months is 8.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.47, a number that is poised to hit 1.71 in the next quarter and is forecasted to reach 9.17 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
The latest stats from [CVS Health Corp, CVS] show that its last 5-days average volume of 7.79 million was inferior to 11.02 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 2.72%. Additionally, its Average True Range was 1.77.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 11.67%, which indicates a significant increase from 2.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.66% in the past 14 days, which was higher than the 24.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $75.65, while its 200-day Moving Average is $72.74. Now, the first resistance to watch is $69.56. This is followed by the second major resistance level at $70.48. The third major resistance level sits at $71.10. If the price goes on to break the first support level at $68.02, it is likely to go to the next support level at $67.40. Assuming the price breaks the second support level, the third support level stands at $66.48.
CVS Health Corp (NYSE: CVS) Key Stats
With a market capitalization of 86.38 billion, the company has a total of 1,260,480K Shares Outstanding. Currently, annual sales are 357,776 M while annual income is 8,344 M. The company’s previous quarter sales were 93,813 M while its latest quarter income was 2,046 M.
